We are international
Donate
TEXT SIZE   


Phase II/III THALOMID® Clinical Trials
05.01.08

FOREIGN TRIALS

  • International, Multi-Center, Prospective, Double Randomized, Open Phase III Study Evaluating Thalidomide/Dexamethasone Versus Melphalan/Prednisone as Induction Therapy and Thalidomide/Interferon-Alpha Versus Interferon-Alpha as Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma (01-002-0601)
    Vienna, Austria


 related articles